北京“AI+医疗健康”再上新台阶

Core Insights - Beijing's recent policies on "AI + healthcare" are expected to enhance AI diagnostic capabilities in community health centers and provide opportunities for companies like Eagle Eye Technology to collaborate with medical institutions [1][2] Group 1: Policy Overview - The two policies are the "Action Plan for Supporting the Development of AI Applications in Healthcare (2026-2027)" and "Several Measures to Support the Innovative Development of AI Industry in Healthcare (2026-2027)" [1] - The Action Plan aims for widespread application of AI technology in the entire healthcare process by 2027, ensuring better medical services for the public [1] - The Measures focus on clinical needs, data governance, support systems, and policy guarantees to establish a robust AI industry support system in healthcare by 2027 [1][2] Group 2: Industry Advantages - Beijing has a complete AI industry chain and is home to numerous leading tech R&D companies, as well as the highest number of tertiary hospitals and national medical centers in China [2] - The establishment of a national AI application pilot base in Beijing by 2025 will focus on precision diagnosis and biopharmaceutical manufacturing [2] Group 3: Implementation in Community Healthcare - Community health centers, like the Ganjiaokou Community Health Service Center, are actively seeking AI assistance to improve diagnostic capabilities, particularly in areas like lung nodule assessment and eye disease evaluation [3] - AI-assisted evaluation of eye diseases is already being implemented in 48 community healthcare institutions in Haidian, facilitated by Eagle Eye Technology [3] Group 4: Data Governance and Collaboration - The new policies emphasize the importance of data governance and the creation of high-quality data sets to support AI development [4] - Measures include accelerating the construction of a comprehensive health information platform and establishing data desensitization and labeling standards to ensure data security and promote data circulation [4][5] - The policies encourage deep collaboration between enterprises and medical institutions to better understand clinical needs and optimize AI algorithms [4][5]